Good to hear from you. I believe we both made good choice today.
RAC has rediscovered Bisantrene that was proven effective by a report last June that two French girls suffering childhood AML are still alive after receiving Bisantrene treatment in 1983 and 1991 respectively. Both ladies have their own childrens now.
RAC could have PRV voucher from FDA once paediatric AMLtrial succeeds which needs IND to be approved by FDA first. IND is the ultimate technical dossier for use in licensing discussions. Also PRV can be worth a value of more than US$100 million. RAC seems to prefer selling it. Then our sp could be worth 15-20 times more?
We can see how important IND is.
GLTAH.
Ann: First patient treated in Bisantrene trial in Israel, page-22
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |